Post‐marketing dosing changes in the label of biologicals

AIM: The aim of this study was to evaluate post‐marketing label changes in dosing information of biologicals. METHODS: Biologicals authorized between 2007 and 2014 by the European Medicines Agency (EMA) were included and followed up from marketing authorization until 31 December 2016 or date of with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Clin Pharmacol
Hlavní autoři: Minnema, Lotte A., Giezen, Thijs J., Gardarsdottir, Helga, Egberts, Toine C. G., Leufkens, Hubert G. M., Mantel‐Teeuwisse, Aukje K.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6422665/
https://ncbi.nlm.nih.gov/pubmed/30593087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13843
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky